113 related articles for article (PubMed ID: 29969588)
1. Desmoglein 3 - Influence on oral carcinoma cell migration and invasion.
Hoque Apu E; Akram SU; Rissanen J; Wan H; Salo T
Exp Cell Res; 2018 Sep; 370(2):353-364. PubMed ID: 29969588
[TBL] [Abstract][Full Text] [Related]
2. DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis.
Chen YJ; Chang JT; Lee L; Wang HM; Liao CT; Chiu CC; Chen PJ; Cheng AJ
Oncogene; 2007 Jan; 26(3):467-76. PubMed ID: 16878157
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic monoclonal antibody against desmoglein 3 augments desmoglein 3 and p38 MAPK phosphorylation in human squamous carcinoma cell line.
Kawasaki Y; Aoyama Y; Tsunoda K; Amagai M; Kitajima Y
Autoimmunity; 2006 Nov; 39(7):587-90. PubMed ID: 17101502
[TBL] [Abstract][Full Text] [Related]
4. Novel human lymph node-derived matrix supports the adhesion of metastatic oral carcinoma cells.
Naakka E; Wahbi W; Tiikkaja R; Juurikka K; Sandvik T; Koivunen P; Autio T; Tikanto J; Väisänen J; Tuominen H; Talvensaari-Mattila A; Al-Samadi A; Soliymani R; Åström P; Risteli M; Salo T
BMC Cancer; 2023 Aug; 23(1):750. PubMed ID: 37580662
[TBL] [Abstract][Full Text] [Related]
5. Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma.
Ghosh S; Munshi HG; Sen R; Linz-McGillem LA; Goldman RD; Lorch J; Green KJ; Jones JC; Stack MS
Cancer; 2002 Dec; 95(12):2524-33. PubMed ID: 12467066
[TBL] [Abstract][Full Text] [Related]
6. Generation of an anti-desmoglein 3 antibody without pathogenic activity of pemphigus vulgaris for therapeutic application to squamous cell carcinoma.
Funahashi SI; Kawai S; Fujii E; Taniguchi K; Nakano K; Ishikawa S; Aburatani H; Suzuki M
J Biochem; 2018 Dec; 164(6):471-481. PubMed ID: 30239818
[TBL] [Abstract][Full Text] [Related]
7. PTEN deletion potentiates invasion of colorectal cancer spheroidal cells through 3D Matrigel.
Chandrasekaran S; Deng H; Fang Y
Integr Biol (Camb); 2015 Mar; 7(3):324-34. PubMed ID: 25625883
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
[TBL] [Abstract][Full Text] [Related]
9. Laminin-derived peptide AG73 regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and beta1 integrin.
Siqueira AS; Gama-de-Souza LN; Arnaud MV; Pinheiro JJ; Jaeger RG
Tumour Biol; 2010 Jan; 31(1):46-58. PubMed ID: 20237901
[TBL] [Abstract][Full Text] [Related]
10. The high affinity heparin-binding domain and the V region of fibronectin mediate invasion of human oral squamous cell carcinoma cells in vitro.
Kapila YL; Niu J; Johnson PW
J Biol Chem; 1997 Jul; 272(30):18932-8. PubMed ID: 9228073
[TBL] [Abstract][Full Text] [Related]
11. Slug is a downstream mediator of transforming growth factor-beta1-induced matrix metalloproteinase-9 expression and invasion of oral cancer cells.
Joseph MJ; Dangi-Garimella S; Shields MA; Diamond ME; Sun L; Koblinski JE; Munshi HG
J Cell Biochem; 2009 Oct; 108(3):726-36. PubMed ID: 19681038
[TBL] [Abstract][Full Text] [Related]
12. The critical effects of matrices on cultured carcinoma cells: Human tumor-derived matrix promotes cell invasive properties.
Wahbi W; Naakka E; Tuomainen K; Suleymanova I; Arpalahti A; Miinalainen I; Vaananen J; Grenman R; Monni O; Al-Samadi A; Salo T
Exp Cell Res; 2020 Apr; 389(1):111885. PubMed ID: 32017929
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of the suppressor potential of conditioned medium from benign myoepithelial cells from pleomorphic adenoma in malignant cell invasion.
da Silva AD; Silva CA; Montalli VA; Martinez EF; de Araújo VC; Furuse C
J Oral Pathol Med; 2012 Sep; 41(8):610-4. PubMed ID: 22680065
[TBL] [Abstract][Full Text] [Related]
14. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.
Kokenyesi R; Murray KP; Benshushan A; Huntley ED; Kao MS
Gynecol Oncol; 2003 Apr; 89(1):60-72. PubMed ID: 12694655
[TBL] [Abstract][Full Text] [Related]
15. Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1.
Shirakata Y; Amagai M; Hanakawa Y; Nishikawa T; Hashimoto K
J Invest Dermatol; 1998 Jan; 110(1):76-8. PubMed ID: 9424092
[TBL] [Abstract][Full Text] [Related]
16. The hypoxic tumor microenvironment regulates invasion of aggressive oral carcinoma cells.
Teppo S; Sundquist E; Vered M; Holappa H; Parkkisenniemi J; Rinaldi T; Lehenkari P; Grenman R; Dayan D; Risteli J; Salo T; Nyberg P
Exp Cell Res; 2013 Feb; 319(4):376-89. PubMed ID: 23262025
[TBL] [Abstract][Full Text] [Related]
17. Comparative Transcriptome Analysis Identifies Desmoglein-3 as a Potential Oncogene in Oral Cancer Cells.
Wan H; Teh MT; Mastroianni G; Ahmad US
Cells; 2023 Nov; 12(23):. PubMed ID: 38067138
[TBL] [Abstract][Full Text] [Related]
18. Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion.
Hanakawa Y; Matsuyoshi N; Stanley JR
J Invest Dermatol; 2002 Jul; 119(1):27-31. PubMed ID: 12164920
[TBL] [Abstract][Full Text] [Related]
19. A novel human leiomyoma tissue derived matrix for cell culture studies.
Salo T; Sutinen M; Hoque Apu E; Sundquist E; Cervigne NK; de Oliveira CE; Akram SU; Ohlmeier S; Suomi F; Eklund L; Juusela P; Åström P; Bitu CC; Santala M; Savolainen K; Korvala J; Paes Leme AF; Coletta RD
BMC Cancer; 2015 Dec; 15():981. PubMed ID: 26673244
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of desmoglein 2 and desmoglein 3 in esophageal squamous cell carcinoma.
Fang WK; Gu W; Liao LD; Chen B; Wu ZY; Wu JY; Shen J; Xu LY; Li EM
Asian Pac J Cancer Prev; 2014; 15(2):871-6. PubMed ID: 24568510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
